Corvascular Plans 2002 NDA Submission For Transarrest Device/Drug Combo
This article was originally published in The Gray Sheet
Executive Summary
Corvascular is set to begin a pivotal Phase III study this year of the Transarrest drug/device combination in anticipation of an early 2002 new drug application submission for use in off-pump coronary artery bypass graft (CABG) surgery.